期刊
NEURAL REGENERATION RESEARCH
卷 16, 期 9, 页码 1882-1889出版社
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/1673-5374.306090
关键词
chemokines; cytokines; fibroblast growth factor; gene therapy; growth factors; peripheral nerve system; sciatic nerve regeneration; vascular endothelial growth factor
资金
- Russian Government Program of Competitive Growth of Kazan Federal University
- Ministry of Education and Science of Russian Federation [20.5175.2017/6.7]
- Russian Federation
- Russian Government Program of Competitive Growth of the Kazan Federal University
- Russian Foundation for Basic Research [18-54-45023 Ind_a]
The plasmid construct pBud-coVEGF165-coFGF2 possesses no immunogenicity and biosafety when injected into the intact rat sciatic nerve, showing significant changes in pro-angiogenic stimuli and levels of cytokines in peripheral blood, suggesting systemic effects. Transient expression of growth factors and active transport of transcripts in the sciatic nerve indicate its potential for nerve regeneration when used as a gene therapy drug.
Vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2) are well-known growth factors involved in the regeneration of various tissues and organs, including peripheral nerve system. In the present study, we elucidated the local and systemic effects of plasmid construct pBud-coVEGF165-coFGF2 injected into the epineurium of intact rat sciatic nerve. Results of histological examination of sciatic nerve and multiplex immunoassays of serum showed the absence of immunogenicity and biosafety of plasmid pBud-coVEGF165-coFGF2. Moreover, local administration of plasmid DNA construct resulted in significantly decreased levels of pro-inflammatory cytokines in the peripheral blood, including tumor necrosis factor alpha (TNF alpha) and interleukin-12, and significantly increased levels of cytokines and chemokines including Regulated upon Activation, Normal T Cell Expressed and Presumably Secrete (RANTES), epidermal growth factor, interleukin-2, and monocyte chemoattractant protein 1. These changes in the peripheral blood on day 7 after injection of plasmid construct pBud-coVEGF165-coFGF2 show that the plasmid construct has systemic effects and may modulate immune response. At the same time, reverse transcription-polymerase chain reaction revealed transient expression of coFGF2, coVEGF165, ratFGF2 and ratVEGFA with direct transport of transcripts from distal part to proximal part of the sciatic nerve. Immunohistochemical staining revealed prolonged presence of VEGFA in sciatic nerve till 14 days post-injection. These findings suggest that local administration of plasmid construct pBud-coVEGF165-coFGF2 at a concentration of 30 ng/mu L results in the formation of pro-angiogenic stimuli and, and the plasmid construct, used as a drug for gene therapy, might potentially facilitate regeneration of the sciatic nerve.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据